Search | IOVS | ARVO Journals

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Novel corticosteroid class reduces inflammation and lowers IOP in animal models

Kevin Carbajal; Maria V. Zaretskaia; Cyndi L. Lichorowic; Jill M. Sturdivant; Meredith Weksler; Alan McDougal; Cheng-Wen Lin; Mitchell A. deLong; Casey Kopczynski; David A. Hollander; Jeff White

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1302. doi:

ARVO Annual Meeting Abstract June 2021

Ocular pharmacokinetics of a novel class of corticosteroids with ROCK inhibitory activity and potential for reduced steroid-associated risks

Maria V. Zaretskaia; Kevin Carbajal; Cyndi L. Lichorowic; Jill M. Sturdivant; Monica Germann; Christopher Romeo; Karen Crews; Angie Glendenning; Meredith Weksler; Alan McDougal; Mitchell A. deLong; Cheng-Wen Lin; Casey Kopczynski; David A. Hollander; Jeff White

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1292. doi:

ARVO Annual Meeting Abstract June 2020

A novel corticosteroid with ROCK inhibitory activity can reduce ocular inflammation and lower IOP in animal models

Kevin Carbajal; Maria V. Zaretskaia; Cyndi Lichorowic; Jill M. Sturdivant; Eric C Carlson; Monica Germann; Karen Crews; Meredith Weksler; Alan McDougal; Mitchell A. deLong; Casey Kopczynski; Cheng-Wen Lin

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2953. doi:

ARVO Annual Meeting Abstract June 2020

Novel corticosteroids with inhibitory activity against ROCK reach target ocular tissues and reduce inflammation in EIU

Maria V Zaretskaia; Kevin Carbajal; Cyndi Lichorowic; Jill M. Sturdivant; Eric C Carlson; Monica Germann; Karen Crews; Meredith Weksler; Alan McDougal; Mitchell A. deLong; Casey Kopczynski; Cheng-Wen Lin

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2983. doi:

Advertisement